Seeing Is Believing
IMRX is currently covered by 4 analysts with an average price target of $19.13. This is a potential upside of $10.86 (280.32%) from yesterday's end of day stock price of $5.03.
Immuneering Corp's activity chart (see below) currently has 23 price targets and 46 ratings on display. The stock rating distribution of IMRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 26.29% with an average time for these price targets to be met of 91.94 days.
Highest price target for IMRX is $30, Lowest price target is $11, average price target is $19.13.
Most recent stock forecast was given by AMI FADIA from NEEDHAM on 20-Jul-2026. First documented stock forecast 24-Aug-2021.
Currently out of the existing stock ratings of IMRX, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Dec-2023
$18
$12.94 (255.73%)
$11
Buy Since 08-Jul-2022
$20
$15.24 (320.17%)
$20
Buy Since 02-Apr-2024
$12
$7.24 (152.10%)
$10
Buy Since 25-Sep-2025
$30
$25.24 (530.25%)
Hold Since 08-May-2024
$3.5
$-1.26 (-26.47%)
What is IMRX (Immuneering Corp) average time for price targets to be met?
Which analyst has the current highest performing score on IMRX (Immuneering Corp) with a proven track record?
Which analyst has the most public recommendations on IMRX (Immuneering Corp)?
Which analyst is the currently most bullish on IMRX (Immuneering Corp)?
Which analyst is the currently most reserved on IMRX (Immuneering Corp)?